BioAdaptives, Inc.
BDPT
$0.0006
$0.000120.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 28.50K | 25.30K | 13.00K | 15.00K | 17.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.50K | 25.30K | 13.00K | 15.00K | 17.10K |
| Cost of Revenue | 17.70K | 16.20K | 6.50K | 7.90K | 10.10K |
| Gross Profit | 10.90K | 9.20K | 6.50K | 7.20K | 7.10K |
| SG&A Expenses | 211.60K | 163.90K | 179.30K | 244.10K | 366.80K |
| Depreciation & Amortization | 28.20K | 39.70K | 6.60K | 29.70K | 62.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 257.60K | 219.90K | 192.40K | 281.70K | 439.10K |
| Operating Income | -228.90K | -194.40K | -179.20K | -266.60K | -421.90K |
| Income Before Tax | -712.50K | -472.50K | -735.70K | -815.60K | -895.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.71 | -0.47 | -0.74 | -0.82 | -0.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -712.50K | -472.50K | -735.70K | -815.60K | -895.50K |
| EBIT | -228.90K | -194.40K | -179.20K | -266.60K | -421.90K |
| EBITDA | -182.90K | -154.80K | -172.80K | -237.00K | -359.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 2.23B | 1.63B | 989.71M | 615.51M | 401.79M |
| Average Diluted Shares Outstanding | 2.23B | 1.63B | 989.71M | 615.51M | 401.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
